InvestorsHub Logo
icon url

bigone

10/23/19 10:36 AM

#100 RE: imjake #99

Thanks for your remarks. I am getting anxious for this to start to move upward.
icon url

7Card

10/24/19 4:04 PM

#101 RE: imjake #99

LexaGene owns the 2 original patents. Jack is the author.

Biotechs of this nature typically sell between $300M and $800M. Would like to see the upper end.

You are correct about the one time use cartridges being like the razor blade and high margin. They will make a ton on the sale of those. They have a lease to buy program for the LX2 that will make it easy for anyone to afford to own one. That will be a big assist for sales too.